All stock lists
Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
Healthcare · Diagnostics & Research
404.45+0.50 (+0.12%)
Insider Score
––Not scored
NTRA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
NTRA analyst forecast
NTRA analyst consensus
No analyst ratings in the last 3 months.
NTRA 12-month price target
$275.00-32.1% downsideaverage of 7 firms
$375.00High
$172.00Low
Best analysts covering NTRA
No firm covering NTRA has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
NTRA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Robert W. Baird | — | $348.00 | +31.1% | — | 2026-08-07 | |
| Canaccord Genuity | — | $375.00 | +41.3% | — | 2026-08-07 | |
| Guggenheim | — | $290.00 | +10.7% | — | 2026-06-29 | |
| RBC Capital | — | $275.00 | +25.4% | — | 2026-06-11 | |
| Goldman Sachs | — | $245.00 | +10.3% | — | 2026-06-05 | |
| Wells Fargo | — | $220.00 | +0.1% | — | 2026-05-08 | |
| BNP Paribas | — | $172.00 | -10.6% | — | 2025-10-27 | |
| Wells Fargo | — | $175.00 | -3.4% | — | 2025-09-22 | |
| RBC Capital | — | $268.00 | +58.3% | — | 2025-09-02 | |
| Morgan Stanley | — | $195.00 | +28.3% | — | 2025-08-10 | |
| Jefferies | — | $182.00 | +58.9% | — | 2024-11-13 | |
| Robert W. Baird | — | $160.00 | +39.7% | — | 2024-11-13 | |
| Canaccord Genuity | — | $150.00 | +24.3% | — | 2024-10-29 | |
| Piper Sandler | — | $150.00 | +19.9% | — | 2024-09-13 | |
| Canaccord Genuity | — | $145.00 | +22.8% | — | 2024-08-27 | |
| Morgan Stanley | — | $132.00 | +14.5% | — | 2024-08-13 | |
| Robert W. Baird | — | $120.00 | +11.4% | — | 2024-08-09 | |
| Wolfe Research | — | $135.00 | +25.7% | — | 2024-06-25 | |
| Jefferies | — | $142.00 | +33.3% | — | 2024-06-03 | |
| Piper Sandler | — | $120.00 | +16.1% | — | 2024-05-14 | |
| BTIG | — | $125.00 | +18.7% | — | 2024-05-13 | |
| Robert W. Baird | — | $117.00 | +22.4% | — | 2024-05-10 | |
| Bernstein | — | $120.00 | +29.9% | — | 2024-04-05 | |
| Piper Sandler | — | $70.00 | +33.2% | — | 2022-08-17 | |
| Piper Sandler | — | $60.00 | +75.4% | — | 2022-05-15 | |
| Guggenheim | — | $129.00 | +42.5% | — | 2021-05-25 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.